What is SABS's dilution risk score?

SABS has a latest available DilutionScore record of 51/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for SABS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for SABS?

DilutionWatch tracks 25 SEC filing types for SABS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SABS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SABS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SABS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SABS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SABS Dilution Risk Score: 51/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

10

📊 Float Risk

35

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $75M remaining capacity

🔔 Track SABS — Get forecast alerts →

Market Data

Market Cap$275.27M

Shares Outstanding90.99M

Float52.34M

Cash$102.63M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 156.9% shares (2026Q1 vs prior)

79 institutional holders · 93.42M shares

#1 Vivo Capital, LLC 22.84M shares

#2 PERCEPTIVE ADVISORS LLC 12.86M shares

#3 Caligan Partners LP 7.97M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.66M

Days to Cover8.9

% of Float8.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31

4 INSIDER TRANSACTION 2026-03-25

424B5 ATM 2026-03-19

8-K 8K EVENT 2026-03-19

424B5 ATM 2026-03-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual SABS Dilution Snapshot

SAB Biotherapeutics, Inc. (SABS) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $75.0M.
Stored outstanding warrants: 2.8M.
Recent SEC activity tracked for SABS: xbrl on 2026-03-31; 4 on 2026-03-25; 424B5 on 2026-03-19.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.